Skip to content

Clinical Investigation to evaluate user experience with the CATALYS Precision Laser System cOS 6.0

Clinical Investigation to evaluate user experience with the CATALYS Precision Laser System cOS 6.0 - CAST-101-OS60

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00020773
Enrollment
72
Registered
2020-05-27
Start date
2020-06-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

h25 H26

Interventions

Group 1: Subjects scheduled for cataract surgery will undergo preoperative testing with the Cassini Total Corneal Astigmatism instrument. The measurements will be imported into the CATALYS system and

Sponsors

Johnson & Johnson Surgical Vision, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to No maximum

Inclusion criteria

Inclusion criteria: • Minimum 22 years of age • Cataracts for which cataract extraction and posterior chamber IOL implantation have been planned • Availability, willingness, sufficient cognitive awareness to comply with examination procedures • Clear intraocular media other than cataract • At least 0.5D of corneal cylinder (measured by Cassini or other keratometer or corneal topographer for which arcuate corneal incisions or use of toric IOL are planned • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.

Exclusion criteria

Exclusion criteria: • Any condition in the study eye which, in the Investigator's opinion, would confound the study results. • Pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils) • Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.) • Concurrent participation or participation in any other interventional clinical trial during the duration of this clinical study including 30 days prior to study visit • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes

Design outcomes

Primary

MeasureTime frame
“Overall clinical acceptability” will be calculated as the average score of the surgeon’s ratings for the following five questions on a five point rating scale* for each treated eye: o Satisfaction with import of preop diagnostic data o Satisfaction with automated input of arcuate incision parameter into treatment plan o Satisfaction with Iris registration o Satisfaction with steep meridian marking o Overall rating of satisfaction with workflow

Secondary

MeasureTime frame
Rate of complications and adverse events

Countries

Germany

Contacts

Public ContactSimone Beuter

Johnson & Johnson Vision

SBeuter@its.jnj.com+49 7243729449

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026